fbpx
  Previous   Next
HomeBusinessSensex Slips 600 points, Nifty Ends Below 17,800

Sensex Slips 600 points, Nifty Ends Below 17,800

Benchmark indices ended lower on January 20 on the back of continues profit booking, with Nifty closing below 17800.

At close, the Sensex was down 634.20 points or 1.06% at 59,464.62, and the Nifty was down 181.40 points or 1.01% at 17,757. About 1593 shares have advanced, 1606 shares declined, and 64 shares are unchanged.

Bajaj Finserv, Infosys, TCS, Divis Lab and Bajaj Auto were the top Nifty losers, while gainers included Power Grid Corporation, Bharti Airtel, Grasim Industries, JSW Steel and Britannia Industries.

Except power, realty and metal, all other sectoral indices are trading in the red with auto, IT, FMCG and pharma indices down 0.8-1.7 percent. BSE midcap and smallcap indices ended flat.

JM Financial Private Equity has finalized a total investment round of Rs 1,000 mn, along with co-investors, as a part of Series B fund raise in a Bengaluru based agri-digital platform, BigHaat Agro Pvt Ltd, to fund the Company’s current growth plans.

Beyond Next Ventures, one of the earlier investors in BigHaat also participated in the fund raise. Proceeds from the investment will support augmentation of the existing technology infrastructure and accelerate expansion of the company’s operations.

This marks the closing of the ninth investment by JM Financial India Fund II. Set up in 2015, BigHaat functions on a unique direct-to-farmer model and is transforming the agriculture value chain by leveraging science, data and technology.

JM Financial was quoting at Rs 74.70, up Rs 0.05, or 0.07 percent on the BSE.

SMS Pharmaceuticals has received a non-exclusive license through the Medicines Patent Pool (MPP) to manufacture molnupiravir, an investigational antiviral Covid-19 medicine, to increase broad access of treatment in 105 low-and middle income countries (UMIC).

SMS Pharmaceuticals was quoting at Rs 136.50, up Rs 5.40, or 4.12 percent on the BSE.

Strides Pharma Science announced its partnership with Medicines Patent Pool (MPP) to commercialize molnupiravir in the international markets, as per the company release.

Strides Pharma Science was quoting at Rs 421.55, down Rs 0.30, or 0.07 percent on the BSE.

Bajaj Finserv has posted 2.6 percent fall in its Q3 net profit at Rs 1,256 crore against Rs 1,289 crore and revenue was up 10.2% at Rs 17,587 crore versus Rs 15,958 crore, YoY.

Bajaj Finserv was quoting at Rs 17,248.40, down Rs 839.15, or 4.64 percent on the BSE.

More News

India Will Have 1 Billion Smartphone Users By 2026

Giving a thrust on domestic manufacturing, Prime Minister Narendra Modi on Tuesday said that mobile manufacturing units have increased from just two in 2014...

Cataract Could Soon Be Treated With Drugs

A revolutionary new treatment for cataract has shown extremely positive results in laboratory tests, giving hope that the condition, which currently can only be...

Punjab CM Bhagwant Mann Has Decides To Abandon Special Cells In Jails For VIP Prisoners

In a major crackdown on the nexus of gangsters and criminals operating from jails, the Punjab government teams have confiscated 710 mobile phones from...

RELATED NEWS

India Will Have 1 Billion Smartphone Users By 2026

Giving a thrust on domestic manufacturing, Prime Minister Narendra Modi on Tuesday said that mobile manufacturing units have increased from just two in 2014...

Electric Vehicle Maker Rivian On Track To Build 25,000 Vehicles In 2022

Electric vehicle maker Rivian Automotive maintained its 2022 production target, saying it’s still on track to build 25,000 vehicles this year, as it reported...

Elon Musk Says Businesses And Governments Accounts Likely To Pay To Use Twitter

Elon Musk has said that businesses and governments may soon need to pay a “slight cost” to use Twitter just weeks after announcing he...